Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 41

1.

Vitamin D prohormone in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease.

Friedl C, Zitt E.

Int J Nephrol Renovasc Dis. 2017 May 11;10:109-122. doi: 10.2147/IJNRD.S97637. eCollection 2017. Review.

2.

Mortality in dialysis patients with cinacalcet use: A large observational registry study.

Friedl C, Reibnegger G, Kramar R, Zitt E, Pilz S, Mann JFE, Rosenkranz AR.

Eur J Intern Med. 2017 Jul;42:89-95. doi: 10.1016/j.ejim.2017.05.002. Epub 2017 May 10.

PMID:
28499709
3.

An unusual case of acute kidney injury after colonoscopy.

Lhotta K, Zitt E.

Kidney Int. 2017 Apr;91(4):989. doi: 10.1016/j.kint.2016.11.020. No abstract available.

PMID:
28314582
4.

Response to active hepatitis B vaccination and mortality in incident dialysis patients.

Zitt E, Hafner-Giessauf H, Wimmer B, Herr A, Horn S, Friedl C, Sprenger-Mähr H, Kramar R, Rosenkranz AR, Lhotta K.

Vaccine. 2017 Feb 1;35(5):814-820. doi: 10.1016/j.vaccine.2016.12.032. Epub 2016 Dec 31.

5.

Prevalence of the Janus Kinase 2 V617F Mutation in Patients with End-Stage Renal Disease.

Muendlein A, Ebner J, Zitt E.

Nephron. 2017;135(3):242. doi: 10.1159/000453080. Epub 2016 Nov 26. No abstract available.

PMID:
27889755
6.

Acute Kidney Injury Treated with Dialysis outside the Intensive Care Unit: A Retrospective Observational Single-Center Study.

Sprenger-Mähr H, Zitt E, Lhotta K.

PLoS One. 2016 Sep 27;11(9):e0163512. doi: 10.1371/journal.pone.0163512. eCollection 2016.

7.

Anthropometric and Metabolic Risk Factors for ESRD Are Disease-Specific: Results from a Large Population-Based Cohort Study in Austria.

Zitt E, Pscheidt C, Concin H, Kramar R, Lhotta K, Nagel G.

PLoS One. 2016 Aug 18;11(8):e0161376. doi: 10.1371/journal.pone.0161376. eCollection 2016.

8.

Successful Treatment of Focal Segmental Glomerulosclerosis after Kidney Transplantation with Plasma Exchange and Abatacept in a Patient with Juvenile Rheumatoid Arthritis.

Sprenger-Mähr H, Zitt E, Soleiman A, Lhotta K.

Case Rep Transplant. 2016;2016:7137584. doi: 10.1155/2016/7137584. Epub 2016 Mar 20.

9.

[Management of secondary hyperparathyroidism-current impact of parathyroidectomy].

Zitt E, Lhotta K.

Wien Med Wochenschr. 2016 May;166(7-8):254-8. doi: 10.1007/s10354-016-0444-3. Epub 2016 Feb 25. Review. German.

PMID:
26913524
10.

Autosomal dominant tubulointerstitial kidney disease caused by uromodulin mutations: seek and you will find.

Raffler G, Zitt E, Sprenger-Mähr H, Nagel M, Lhotta K.

Wien Klin Wochenschr. 2016 Apr;128(7-8):291-4. doi: 10.1007/s00508-015-0948-7. Epub 2016 Jan 25.

PMID:
26810206
11.

Sex- and Time-Dependent Patterns in Risk Factors of End-Stage Renal Disease: A Large Austrian Cohort with up to 20 Years of Follow-Up.

Pscheidt C, Nagel G, Zitt E, Kramar R, Concin H, Lhotta K.

PLoS One. 2015 Aug 31;10(8):e0135052. doi: 10.1371/journal.pone.0135052. eCollection 2015.

12.

Efficacy and safety of body weight-adapted oral cholecalciferol substitution in dialysis patients with vitamin D deficiency.

Zitt E, Sprenger-Mähr H, Mündle M, Lhotta K.

BMC Nephrol. 2015 Aug 4;16:128. doi: 10.1186/s12882-015-0116-3.

13.

Iron supplementation and mortality in incident dialysis patients: an observational study.

Zitt E, Sturm G, Kronenberg F, Neyer U, Knoll F, Lhotta K, Weiss G.

PLoS One. 2014 Dec 2;9(12):e114144. doi: 10.1371/journal.pone.0114144. eCollection 2014.

14.

Variable mechanisms of vascular calcification in different segments of the arterial tree in patients with chronic kidney disease.

Zitt E, Knoll F, Lhotta K.

Kidney Int. 2014 Oct;86(4):858. doi: 10.1038/ki.2014.183. No abstract available.

PMID:
25265960
15.

Medullary nephrocalcinosis in an adult patient with idiopathic infantile hypercalcaemia and a novel CYP24A1 mutation.

Meusburger E, Mündlein A, Zitt E, Obermayer-Pietsch B, Kotzot D, Lhotta K.

Clin Kidney J. 2013 Apr;6(2):211-215. Epub 2013 Mar 3. Erratum in: Clin Kidney J. 2013 Aug;6(4):453.

16.

Body mass index and metabolic factors predict glomerular filtration rate and albuminuria over 20 years in a high-risk population.

Nagel G, Zitt E, Peter R, Pompella A, Concin H, Lhotta K.

BMC Nephrol. 2013 Aug 20;14:177. doi: 10.1186/1471-2369-14-177.

17.

Erratum: Medullary nephrocalcinosis in an adult patient with idiopathic infantile hypercalcaemia and a novel CYP24A1 mutation.

Meusburger E, Mündlein A, Zitt E, Obermayer-Pietsch B, Kotzot D, Lhotta K.

Clin Kidney J. 2013 Aug;6(4):453. doi: 10.1093/ckj/sft091.

18.

Serum phosphorus reduction in dialysis patients treated with cinacalcet for secondary hyperparathyroidism results mainly from parathyroid hormone reduction.

Zitt E, Fouque D, Jacobson SH, Malberti F, Ryba M, Ureña P, Rix M, Dehmel B, Manamley N, Vervloet M.

Clin Kidney J. 2013 Jun;6(3):287-294. Epub 2013 Apr 11.

19.

Lipoprotein kinetics in male hemodialysis patients treated with atorvastatin.

Schwaiger JP, Nakada Y, Berberich R, Ikewaki K, Dieplinger B, Zitt E, Neyer U, Salmhofer H, Kronenberg F, Koenig P, Dieplinger H.

Clin J Am Soc Nephrol. 2013 Aug;8(8):1319-26. doi: 10.2215/CJN.10881012. Epub 2013 Apr 18.

20.

Use of sodium thiosulphate in a multi-interventional setting for the treatment of calciphylaxis in dialysis patients.

Zitt E, König M, Vychytil A, Auinger M, Wallner M, Lingenhel G, Schilcher G, Rudnicki M, Salmhofer H, Lhotta K.

Nephrol Dial Transplant. 2013 May;28(5):1232-40. doi: 10.1093/ndt/gfs548. Epub 2013 Jan 4.

PMID:
23291368

Supplemental Content

Loading ...
Support Center